Summary
For Year 2026-27, Astrazeneca Pharma India reports the following shareholding: Total Promoters at 75%, Mutual Fund at 5.66%, Insurance at 0.06%, Foreign Institutional Investors at 2.78%, Domestic Institutional Investors at 0.06%, and Retail at 16.44%. This breakdown provides a quick snapshot of ownership distribution for Astrazeneca Pharma India in 2026-27.
Astrazeneca Pharma India FAQs
As of 04-2026, the promoter shareholding in Astrazeneca Pharma India stands at 75% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Astrazeneca Pharma India is 2.78% and 0.06% respectively.
The retail shareholding of the Astrazeneca Pharma India is 16.44%.
Changes in shareholding patterns of Astrazeneca Pharma India can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Astrazeneca Pharma India are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Astrazeneca Pharma India Associated Pages
- Astrazeneca Pharma India Share Price
- Astrazeneca Pharma India Share Price chart
- Astrazeneca Pharma India Fundamental Analysis
- Astrazeneca Pharma India Technical Analysis
- Astrazeneca Pharma India Peer Comparison
- Astrazeneca Pharma India Share Price History
- Astrazeneca Pharma India Dividend
- Astrazeneca Pharma India Board of Directors
